Published in J Gen Intern Med on April 27, 2010
Living Donor Kidney Transplantation: Overcoming Disparities in Live Kidney Donation in the US--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.99
Profile of infections in renal transplant recipients from India. J Family Med Prim Care (2017) 0.75
The transplant patient and transplant medicine in family practice. J Family Med Prim Care (2015) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med (2008) 14.01
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis (2007) 8.79
Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension (2008) 7.99
Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2004) 7.89
Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA (2001) 7.63
Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis (2005) 6.85
Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA (2007) 5.89
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet (2007) 5.74
Infection in solid-organ transplant recipients. N Engl J Med (2007) 5.47
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol (1998) 4.67
Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet (2003) 4.19
Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med (2005) 4.04
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis (2007) 3.96
Renal transplantation. N Engl J Med (1994) 3.33
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11
Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int (2007) 2.69
State-specific prevalence of obesity among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 2.58
Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med (2003) 2.56
II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis (2006) 2.52
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int (2009) 2.30
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant (2003) 2.21
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int (2007) 2.10
Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol (2007) 1.95
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev (2007) 1.88
Cardiovascular complications after renal transplantation and their prevention. Transplantation (2006) 1.86
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet (2007) 1.79
Colchicine myopathy and neuropathy. N Engl J Med (1987) 1.77
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Cyclosporine-induced hyperuricemia and gout. N Engl J Med (1989) 1.67
Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol (2000) 1.60
Hypertension after kidney transplantation. Am J Kidney Dis (2004) 1.59
Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition (2002) 1.51
Malignancy in renal transplantation. J Am Soc Nephrol (2004) 1.50
Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens (2004) 1.50
Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation. Transplantation (1996) 1.48
Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis (2007) 1.47
Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? Transplantation (2003) 1.47
Obesity and outcome following renal transplantation. Am J Transplant (2006) 1.46
Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis (1999) 1.46
Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis (2004) 1.45
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency. Diabetes Obes Metab (2008) 1.44
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
Use of sirolimus in solid organ transplantation. Drugs (2007) 1.40
Urinary tract infection in the renal transplant patient. Nat Clin Pract Nephrol (2008) 1.38
The OPTN/UNOS Renal Transplant Registry. Clin Transpl (2005) 1.37
Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events. Semin Dial (2007) 1.34
Arterial hypertension and renal allograft survival. JAMA (2000) 1.33
Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol (2006) 1.29
Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev (2003) 1.28
Strategies for reducing exposure to environmental tobacco smoke, increasing tobacco-use cessation, and reducing initiation in communities and health-care systems. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep (2000) 1.27
Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int (1998) 1.26
Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation (1998) 1.26
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant (2004) 1.23
Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis (2008) 1.22
Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant (2005) 1.22
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis (2009) 1.22
Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant (1997) 1.21
Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant (2004) 1.20
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. J Gen Intern Med (2009) 1.19
Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis (2003) 1.17
Trends in kidney transplantation over the past decade. Drugs (2008) 1.17
Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg (2008) 1.16
Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol (2003) 1.16
Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol (2008) 1.13
Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med (1988) 1.11
Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients. Am J Transplant (2005) 1.09
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09
Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant (2007) 1.08
Cigarette smoking in renal transplant recipients. J Am Soc Nephrol (2000) 1.07
Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation (2006) 1.07
New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation (2005) 1.06
Medical care of kidney transplant recipients after the first posttransplant year. Clin J Am Soc Nephrol (2006) 1.05
Management of cardiovascular disease in renal transplant recipients. Clin J Am Soc Nephrol (2008) 1.03
Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant (1999) 1.03
Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation (2006) 1.03
Excess risk of renal allograft loss associated with cigarette smoking. Transplantation (2001) 1.02
Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol (2002) 1.02
Anemia after renal transplantation. Am J Kidney Dis (2006) 1.01
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Antimicrobial-associated QT interval prolongation: pointes of interest. Clin Infect Dis (2006) 2.29
Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Crit Care Med (2015) 2.12
Extracorporeal Treatment for Metformin Poisoning: Systematic Review and Recommendations From the Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med (2015) 2.07
Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol (2009) 1.89
Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol (2012) 1.75
Automated clinical reminders for primary care providers in the care of CKD: a small cluster-randomized controlled trial. Am J Kidney Dis (2011) 1.66
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J Am Coll Cardiol (2013) 1.65
Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol (2010) 1.55
Clopidogrel efficacy and cigarette smoking status. JAMA (2012) 1.52
Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol (2011) 1.45
Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol (2007) 1.43
Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Am J Kidney Dis (2012) 1.26
Health-related quality of life outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens (2010) 1.21
Core competencies for research training in the clinical pharmaceutical sciences. Am J Pharm Educ (2011) 1.21
Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.13
Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience. Clin J Am Soc Nephrol (2013) 1.11
Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol (2010) 1.10
Comparative evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy (2011) 1.03
The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology. Clin Toxicol (Phila) (2012) 1.02
Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study. BMC Nephrol (2011) 0.95
Numeracy skills in CKD: correlates and outcomes. Clin J Am Soc Nephrol (2010) 0.95
Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial (2014) 0.94
Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study. Am J Kidney Dis (2013) 0.93
Effect of hemodialysis on hepatic cytochrome P450 functional expression. J Pharmacol Sci (2008) 0.92
Associations of race with depression and symptoms in patients on maintenance haemodialysis. Nephrol Dial Transplant (2006) 0.91
Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. Semin Dial (2014) 0.90
Current understanding of drug disposition in kidney disease. J Clin Pharmacol (2012) 0.90
Sleep-disordered breathing and frailty in the Cardiovascular Health Study Cohort. Am J Epidemiol (2009) 0.89
Extracorporeal treatment for tricyclic antidepressant poisoning: recommendations from the EXTRIP Workgroup. Semin Dial (2014) 0.89
Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv Chronic Kidney Dis (2010) 0.88
Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease? Curr Opin Nephrol Hypertens (2007) 0.87
Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study. BMC Nephrol (2014) 0.85
Sexual function in women receiving maintenance dialysis. Hemodial Int (2009) 0.85
Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transplant (2010) 0.84
Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study. J Pain Symptom Manage (2010) 0.84
Simultaneous analysis of multiple aminothiols in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.84
Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study. Am J Kidney Dis (2010) 0.84
Sleep quality, mood, alertness and their variability in CKD and ESRD. Nephron Clin Pract (2010) 0.82
Health-related quality of life as a predictor of mortality among survivors of AKI. Clin J Am Soc Nephrol (2012) 0.82
Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) (2014) 0.81
Benefits of short daily home hemodialysis in the FREEDOM Study: is it about person, place, time, or treatment? Kidney Int (2012) 0.80
Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study. Nephrol Dial Transplant (2012) 0.80
Volume overload as a mechanism for obstructive sleep apnea in CKD? Nephrol Dial Transplant (2012) 0.80
Extracorporeal treatment for thallium poisoning: recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol (2012) 0.80
Nonrenal drug clearance in CKD: Searching for the path less traveled. Adv Chronic Kidney Dis (2010) 0.79
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis (2006) 0.79
The anti-oxidant effects are not the main mechanism for glutamine's protective effects on acute kidney injury in mice. Eur J Pharmacol (2013) 0.79
Heart failure severity scoring system and medical- and health-related quality-of-life outcomes: the HEMO study. Am J Kidney Dis (2011) 0.79
In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases. Pharmacotherapy (2013) 0.78
Blood purification in toxicology: nephrology's ugly duckling. Adv Chronic Kidney Dis (2011) 0.77
Aging in kidney disease: key issues and gaps in knowledge. Adv Chronic Kidney Dis (2010) 0.77
Nocturia and aging: diagnosis and treatment. Adv Chronic Kidney Dis (2010) 0.77
Treating hyponatremia: how slow is safe? Central pontine myelinolysis despite appropriate correction of hyponatremia. Eur J Intern Med (2008) 0.76
Acute kidney injury. BMJ Clin Evid (2011) 0.76
Ecological momentary assessment of fatigue, sleepiness, and exhaustion in ESKD. BMC Nephrol (2014) 0.76
Stability of atropine sulfate prepared for mass chemical terrorism. J Toxicol Clin Toxicol (2003) 0.76
Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) (2015) 0.76
Kidney function assessment and its role in drug development, review and utilization. Expert Rev Clin Pharmacol (2014) 0.76
Recognition and treatment of obstructive sleep apnea. Semin Dial (2013) 0.76
Training Residents to Work in a Patient-Centered Medical Home: What Are the Outcomes? J Grad Med Educ (2016) 0.75
A decade after the KDOQI CKD guidelines: impact on medication safety. Am J Kidney Dis (2012) 0.75
Determination of vancomycin and gentamicin clearance in an in vitro, closed loop dialysis system. BMC Nephrol (2014) 0.75
Optimizing drug development and use in patients with kidney disease: opportunities, innovations, and challenges. J Clin Pharmacol (2012) 0.75
Clinical relevance of impaired nonrenal drug clearance in ESRD. Semin Dial (2010) 0.75
On warfarin use in kidney disease: a therapeutic window of opportunity? Am J Kidney Dis (2010) 0.75
A new forum for brief research reports in AJKD. Am J Kidney Dis (2010) 0.75
Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices. Clin J Am Soc Nephrol (2010) 0.75
Thienopyridine efficacy and cigarette smoking status. Am Heart J (2013) 0.75
Implications of Kidney Disease on Metabolic Reduction. Curr Drug Metab (2016) 0.75
What is the role of renal replacement therapy in the setting of dabigatran toxicity? Semin Dial (2014) 0.75
Update in general internal medicine: evidence published in 2011. Ann Intern Med (2012) 0.75
Extracorporeal treatment for theophylline poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) (2015) 0.75